At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, participants engaged in forward-thinking debate, discussion, and data releases across oncology.
Several pivotal topics emerged, establishing predominant themes throughout the conference. Although efficacy continues to be the fundamental basis of oncology treatment decisions, the evolving landscape—characterized by enhanced survival rates, expanding therapeutic options, and increased patient access to multidisciplinary care—necessitates a greater focus on selecting the most suitable approach, prioritizing safety and the patient’s quality of life.
